Study of a single injection of RABI-767 for severe acute pancreatitis
Part of Digestive system clinical trials.
This trial tests a single injection of a new drug called RABI-767, given through a thin tube during an endoscopic ultrasound (EUS), to see if it can help people with severe acute pancreatitis. The drug is meant to reduce inflammation and prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of acute pancreatitis (sudden, severe inflammation of the pancreas).
- Your pancreatitis must be predicted to become severe, based on your doctor's assessment.
- You should not have gotten significantly better since you were admitted to the hospital.
- You must be able to undergo an endoscopic ultrasound (EUS) procedure to receive the study drug.
- You must have a recent CT scan or MRI of your abdomen to check for certain exclusion criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how severe acute pancreatitis works by using advanced tests on your body's germs, chemicals, and proteins. It may help find better ways to treat patients with this condition.
This trial tests infliximab (an anti-inflammatory medicine) versus placebo to see if it improves outcomes in adults with newly diagnosed acute pancreatitis. It is designed for treatment to start within 36 hours of hospital admission.
This trial tests whether an epidural (a numbing shot near the spine) can reduce pain and improve recovery in people with severe pancreatitis who have early problems with their lungs, heart, or kidneys. It is designed for people in the intensive care unit.
This early-phase trial is testing a new endoscopic (from inside the stomach) approach for pancreatic ductal adenocarcinoma that is locally advanced and cannot be removed with surgery. It may help some people who have already tried first chemotherapy and still have a tumor confined to the pancreas area (no spread).
This trial tests a new method using an endoscope (a thin tube with a camera) to deliver a chemotherapy drug directly into a pancreatic cyst called IPMN. The goal is to see if this approach is safe and can prevent the cyst from growing or turning into cancer.
This trial is studying how often pancreatitis happens after a common bile duct procedure called ERCP, and how a standard safety protocol might help prevent it. It aims to include people who need a therapeutic ERCP (treatment, not just diagnosis) to learn more about safe practices.
Hear when a new Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.